Member Info for Bonzo73

@Wessy1 I agree.....I've been on the Author42 platform today. There have definitely been developments. The technology is actually very clever....I personally think the design of the website could be enhanced but the functionality is really interesting and I can now start to understand the value-added benefits it is trying to deliver to both experienced and more novice writers. Exciting stuff!

The price is holding inline with the back end of last week. Fundamentally there are investors here that are taking a long term view and who have confidence that Prof Nag and his team will deliver. His gilded reputation is at stake, aside from his own money he has invested.

RNSs normally come through frequently and I'm confident positive news will drop in the coming week. We also know how this can spring back up quickly.

128 pharma deals were concluded in December 2024 so December cannot be written off as a month for news.

Am I the only one that's holding here for a deal? I work and simply don't have the time to sit watching a screen all day. I feel confident a deal will land that will have been worth holding out for.

Aoologies, sloppy language. They have a considerable 'vested' interest to make it a huge success.

@notready1....I agree

This is uncomfortable but we've been here before on the back of the warrants RNS....shortly after it flew up from 0.002p to 0.009p

My average is a good level higher and I'm not selling at a loss....look at how heavily invested the directors are. With skin in the game, they will be on a mission to make this a huge success.

Volume and value bought today is marginally exceeding volume and value sold. Can anyone explain the drop in SP?

I have to say, it's a brilliant website upgrade. Beautifully designed with clear, punchy messaging. Who wouldn't want to be on board at this transformative time...

Interested to know people's views on how the US listing will take place at the current SP. Are we anticipating a raft of news to lift the price?

Be aware that on the ADVFN site, some people are being open about shorting this share....looks like it's heading back up now. I can't imagine for a minute that Ronjon will allow this to fail....holding for the medium/long term.

@notready....thank you. So they are not linked in any way?

Just been reflecting on the timing of the delivery of completion notice on Creator42

Am I right in thinking this App relies on Author42 App/website being fully up and running.

If the post on LinkedIn yesterday intimated that there are still glitches to be fixed on Author42, would it not have been better to delay the delivery date of Creator42 because the 12 month licensing clock is now ticking.

Very happy to be corrected in my thinking.

I've been looking at some of the competitor websites within the space Capai is trying to play in. At the moment, and I appreciate the Author42 website is in ita Beta phase, much more work needs to be done on getting the front end improved. It doesn't matter how clever the tech inside is, people need to be enticed to click inside.

Simple calls to action on the home page, explaining how the website/app can enhance their way of working/lives. Putting the customer/user at the forefront of their thinking.

It feels as though so much is being brought to market at great speed but it needs to be done properly, to ensure that all parts work to the greater benefit of the whole.

I think we are still some way off having a commercial-ready product and I don't think it would be that difficult to get there. There are some brilliant website designers around who don't charge the earth...hopefully this is already happening behind the scenes.

OK....it's good to know they can be transferred. I'll do the same.

@filbertfox

I too am on ii....no longer able to buy capai but I can sell it....fortunately I also have an account with AJBell but this is frustrating. Ii did the same with ALRT.

@crownos. No problem. I think Companies House may be using web storage with Amazon....hence the reference on the link. An Amazon tie up with Capai would be brilliant for sure but possibly a little premature at this stage. One for the future however.

It's the Articles of Association, adopted by Capai on October 6th 2025. A rather lengthy read of 74 pages. You can find it under Capai on Companies House.

It apparently removes the need for MMs and reduces the spread. Hopefully a positive move and less scope for manipulation, but who knows?

The average NED works 2 to 4 days a month.....would have thought bringing someone in who has a wealth of experience in pharma finance for just a few days a month should pay dividends. Literally.

I have to say, I'm surprised at the reaction to the RNS this morning. I saw it as an entirely positive piece of news. Just goes to show how news lands in different ways.